Safety and clinical activity of durvalumab (MEDI4736), an anti-programmed cell death ligand-1 (PD-L1) antibody, in patients with non-small cell lung cancer (NSCLC)

被引：10

作者：

Antonia, Scott ^{[1
]}

Rizvi, Naiyer ^{[2
]}

Brahmer, Julie ^{[3
]}

Ou, Sai-Hong ^{[4
]}

Khleif, Samir N. ^{[5
]}

Hwu, Wen-Jen ^{[6
]}

Gutierrez, Martin ^{[7
]}

Schoffski, Patrick ^{[8
]}

Hamid, Omid ^{[9
]}

Weiss, Jared ^{[10
]}

Lutzky, Jose ^{[11
]}

Maio, Michele ^{[12
]}

Nemunaitis, John ^{[13
]}

Jaeger, Dirk ^{[14
]}

Balmanoukian, Ani ^{[9
]}

Rebelatto, Marlon C. ^{[15
]}

Steele, Keith E. ^{[15
]}

Jin, Xiaoping ^{[15
]}

Robbins, Paul B. ^{[15
]}

Blake-Haskins, John A. ^{[15
]}

Segal, Neil H. ^{[16
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[2] Columbia Univ, Med Ctr, New York, NY USA

[3] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[4] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA

[5] Georgia Regent Univ, GRU Canc Ctr, Agusta, MD USA

[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[7] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[8] Leuven Canc Inst, Leuven, Belgium

[9] Angeles Clin & Res Inst, Los Angeles, CA USA

[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

[11] Mt Sinai Med Ctr, New York, NY 10029 USA

[12] Univ Hosp Siena, Siena, Italy

[13] Mary Crowley Canc Res Ctr, Dallas, TX USA

[14] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany

[15] Medlmmune, Gaithersburg, MD USA

[16] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

CANCER IMMUNOLOGY RESEARCH | 2016年 / 4卷 / 01期

关键词：

D O I：

10.1158/2326-6074.CRICIMTEATIAACR15-A047

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A047

引用

页数：2